TipRanks
Definium Therapeutics (DFTX)
NASDAQ:DFTX
Want to see DFTX full AI Analyst Report?

Compare Definium Therapeutics (DFTX) vs. Competitors

2,470 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Definium Therapeutics
$44.81
$5.03B
-10.87
206.06%
15 Buy
0 Hold
0 Sell
Strong Buy
AnaptysBio
$58.00
$1.45B
7.19
54.85%
7 Buy
0 Hold
0 Sell
Strong Buy
Enliven Therapeutics
$60.50
$3.44B
-28.64
135.79%
14 Buy
0 Hold
0 Sell
Strong Buy
Tyra Bioscience
$26.22
$1.40B
-8.51
52.58%
11 Buy
0 Hold
0 Sell
Strong Buy
Biohaven Ltd.
$14.38
$1.94B
-2.77
-17.02%
7 Buy
3 Hold
1 Sell
Moderate Buy
Inhibrx Biosciences Inc
$122.72
$1.43B
-10.92
176.60%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DFTX
Definium Therapeutics
37.40
25.18
206.06%
ANAB
AnaptysBio
48.53
28.37
140.69%
ELVN
Enliven Therapeutics
46.97
26.67
131.38%
TYRA
Tyra Bioscience
20.43
7.00
52.12%
BHVN
Biohaven Ltd.
12.87
-3.01
-18.95%
INBX
Inhibrx Biosciences Inc
96.99
62.03
177.43%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts